Opportunities and challenges in the development of kinase inhibitor therapy for cancer

被引：147

作者：

Sawyers, CL ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA

[2] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA

[3] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA

[4] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA

[5] Univ Calif Los Angeles, Jonsson Canc Ctr, Los Angeles, CA 90095 USA

[6] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA

来源：

GENES & DEVELOPMENT | 2003年 / 17卷 / 24期

关键词：

D O I：

10.1101/gad.1152403

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

引用

页码：2998 / 3010

页数：13

共 101 条

[71]

PRADOS M, 2003, P AN M AM SOC CLIN, P394

[72] Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans [J].

Rubin, BP ;

Schuetze, SM ;

Eary, JF ;

Norwood, TH ;

Mirza, S ;

Conrad, EU ;

Bruckner, JD .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3586-3591

[73] Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry [J].

Salomon, AR ;

Ficarro, SB ;

Brill, LM ;

Brinker, A ;

Phung, QT ;

Ericson, C ;

Sauer, K ;

Brock, A ;

Horn, DM ;

Schultz, PG ;

Peters, EC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (02) :443-448

[74] Chronic myeloid leukemia [J].

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (17) :1330-1340

[75] Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study [J].

Sawyers, CL ;

Hochhaus, A ;

Feldman, E ;

Goldman, JM ;

Miller, CB ;

Ottmann, OG ;

Schiffer, CA ;

Talpaz, M ;

Guilhot, F ;

Deininger, MWN ;

Fischer, T ;

O'Brien, SG ;

Stone, RM ;

Gambacorti-Passerini, CB ;

Russell, NH ;

Reiffers, JJ ;

Shea, TC ;

Chapuis, B ;

Coutre, S ;

Tura, S ;

Morra, E ;

Larson, RA ;

Saven, A ;

Peschel, C ;

Gratwohl, A ;

Mandelli, F ;

Ben-Am, M ;

Gathmann, I ;

Capdeville, R ;

Paquette, RL ;

Druker, BJ .

BLOOD, 2002, 99 (10) :3530-3539

[76] CHRONIC MYELOMONOCYTIC LEUKEMIA - TEL-A-KINASE WHAT ETS ALL ABOUT [J].

SAWYERS, CL ;

DENNY, CT .

CELL, 1994, 77 (02) :171-173

[77] Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia [J].

Sawyers, CL .

CANCER CELL, 2002, 1 (05) :413-415

[78] Imatinib GIST keeps finding new indications: successful treatment of dermatotibrosarcoma protuberans by targeted inhibition of the platelet-derived growth factor receptor [J].

Sawyers, CL .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3568-3569

[79] Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase [J].

Schindler, T ;

Bornmann, W ;

Pellicena, P ;

Miller, WT ;

Clarkson, B ;

Kuriyan, J .

SCIENCE, 2000, 289 (5486) :1938-1942

[80] TOR, a central controller of cell growth [J].

Schmelzle, T ;

Hall, MN .

CELL, 2000, 103 (02) :253-262

← 2 3 4 5 6 7 8 9 10 11 →